AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Immudapt-S 180 Tablet DR

Prescription Icon
Prescription Required

Marketer

Biowision Life Sciences Pvt Ltd

Salt Composition

Mycophenolate sodium (180mg)

Overview Immudapt-S 180 Tablet DR

Transplant recipients often use the immunosuppressant, Immudapt-S 180 DR tablets, in conjunction with other medications to mitigate organ rejection (kidney, heart, liver, etc.). Its mechanism involves immune system modulation, preventing the body from attacking the transplanted organ. Dosage is transplant-specific; adhere strictly to your physician's prescription. Consumption with or without food is acceptable; swallow tablets whole – never crush, chew, or break them. Consistent usage is crucial for optimal efficacy; discontinuation increases rejection risk. Treatment duration is determined by your need for rejection prevention. Common adverse effects include gastrointestinal distress (nausea, vomiting, diarrhea, abdominal pain), headache, hypertension, and altered white blood cell counts. Immunosuppression elevates infection susceptibility and cancer risk. A comprehensive list of potential side effects exists; consult your doctor regarding these and any concerning symptoms requiring immediate medical attention. Due to teratogenic potential (causing birth defects and miscarriage), avoid use during pregnancy, preconception, or breastfeeding. Prior to commencing treatment, disclose any infections, unusual bleeding or bruising, or prior digestive issues. Inform your physician about all concurrent medications due to potential interactions impacting Immudapt-S 180 DR efficacy. Regular blood tests monitor blood cell counts; report any unexplained bruising/bleeding, sore throat, mouth sores, or fever promptly.

Uses of Immudapt-S 180 Tablet DR

Post-transplant organ rejection prophylaxis

Major Benefits of Immudapt-S 180 Tablet DR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Immudapt-S 180 Tablet DR can be administered with or without food, though consistent timing is recommended.

Common Side effects of Immudapt-S 180 Tablet DR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Immudapt-S 180 Tablet DR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Immudapt-S 180 Tablet DR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.

How Immudapt-S 180 Tablet DR works:

Immudapt-S 180 DR tablets function as an immunosuppressant, mitigating the body's immune response to prevent organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no reported adverse reactions from concomitant use of Immudapt-S 180 Tablet DR and alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Immudapt-S 180 Tablet DR during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Immudapt-S 180 Tablet DR. Evidence indicates potential infant harm from this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Immudapt-S 180 Tablet DR.

KidneyKidneyCAUTION

For patients with severe kidney impairment, Immudapt-S 180 Tablet DR requires careful administration. Dosage modification of Immudapt-S 180 Tablet DR might be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Immudapt-S 180 Tablet DR in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

What if you forget to take Immudapt-S 180 Tablet DR :

Should you forget to take your Immudapt-S 180 Tablet DR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Immudapt-S 180 Tablet DR

LabelValue
Type of Compound Benzylphthalide-related compound
Potential for Dependence None.
Type of Treatment Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: Purine-based medications

FAQs on Immudapt-S 180 Tablet DR

Azathioprine (the active ingredient in Immudapt-S 180 Tablet DR) is an immunosuppressant medication. This prescription aims to facilitate your body's acceptance of the transplanted kidney. It achieves this by modulating your immune system's response, thereby reducing the rejection of the foreign organ. This action promotes the successful integration of the transplanted kidney.
Taking Immudapt-S 180 Tablet DR may heighten the risk of developing certain cancers, including skin cancer and lymphoma. Minimize sun exposure when outdoors, using protective clothing and sunscreen. Consult your physician immediately if you notice any new skin lesion, a mole changing in size or color, a dark, irregularly shaped skin sore, asymmetrical skin sores, persistent skin alterations, non-healing wounds, unexplained fever, persistent fatigue, weight loss, or lymph node pain or swelling.
Immudapt-S 180 Tablet DR is a non-steroidal, non-chemotherapy immunosuppressant. Its mechanism involves modulating the immune system to prevent organ rejection following transplantation. A frequent adverse reaction associated with Immudapt-S 180 Tablet DR is alopecia.
Prior to commencing treatment with Immudapt-S 180 Tablet DR, a blood test will be necessary as this medication may influence blood cell levels and impact liver and kidney function. Regular blood monitoring is mandated throughout treatment to detect any hematological alterations. This ongoing assessment facilitates monitoring of treatment efficacy and the detection of potential adverse reactions.
Immudapt-S 180 Tablet DR reduces immune system activity; it's an immunosuppressant. Given your compromised immune response, exposure to chickenpox or shingles poses a heightened risk of infection. Your physician's cautionary advice stems from this vulnerability. Adhere to their instructions and seek immediate medical attention should you contract either illness, as specialized care may be necessary.
Avoid Immudapt-S 180 Tablet DR if pregnant or considering pregnancy. First-trimester use carries a significant miscarriage risk and may result in congenital anomalies. Consequently, employ two reliable contraceptive methods concurrently for four weeks prior to, throughout, and six weeks following Immudapt-S 180 Tablet DR treatment. Your physician will recommend appropriate methods. Note that Immudapt-S 180 Tablet DR can reduce oral contraceptive efficacy; therefore, a secondary contraceptive method is crucial.
Reliable birth control should be used by one partner throughout treatment with Immudapt-S 180 Tablet DR and for three months afterward. Male patients must refrain from donating sperm for the duration of therapy and the subsequent 90-day period.
Immudapt-S 180 Tablet DR
526
MRP 641
17% off